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Abstract 
Background: We aimed to evaluate clinically the effect of mouthrinse containing a rice peptide on early dental 
plaque regrowth.
Methods: The study was designed as a double-masked, two-group crossover randomized pilot trial, involving 10 
periodontally healthy volunteers. After receiving a professional tooth cleaning at baseline, over the next 3 days each 
participant refrained from all oral hygiene measures and had two daily rinses with 20 ml of the test mouthrinse 
containing 0.4 % rice peptide CL(14-25) or placebo rinse. At the end of each experimental period, plaque score was 
assessed using the modified Volpe’s method, and the participants filled out a questionnaire. Each participant under-
went a 7-day washout period followed by a second allocation. The plaque score was the primary outcome of the 
study and participant perception was the secondary outcome.
Results: No adverse effects were observed in the participants during the study. Clinically, the mean plaque score 
of the examined teeth was significantly lower in the test group (2.44 ± 0.74, CI: 1.91–2.96) than the placebo group 
(2.65 ± 0.63, CI: 2.20–3.10) (P < 0.05). When analyzed according to the type of teeth, a significantly lower score of 
the premolars/molars was observed in the test group (2.39 ± 0.68, CI: 2.08–2.71) than that in the placebo group 
(2.66 ± 0.58, CI: 2.39–2.93) (P < 0.05).
Conclusions: The mouthrinse containing 0.4 % rice peptide CL(14-25) was effective in reducing the early regrowth of 
dental plaque. However, clinical relevance of this efficacy needs to be validated in a future large-scale study.
Trial registration: UMIN Clinical Trials Registry (UMIN-CTR) R000014000. Date of formal registration: November 1, 2013.
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Background
Periodontal disease is the inflammation of periodontal 
tissue caused by pathogenic microflora in dental plaque 
biofilm [1]. Theoretically, it is possible to prevent plaque-
induced periodontal disease by meticulous mechanical 
oral hygiene. However, many individuals have difficulty 
in maintaining the necessary standards of dental plaque 
control for prolonged periods [2], and the periodontal 
disease remains to be one of the most prevalent diseases 
of humans.
In order to control plaque biofilms, numerous anti-
plaque and antimicrobial agents have been formulated 
into toothpastes and mouthrinses [2–5]. The efficacy of 
those agents used in adjunct to mechanical plaque con-
trol has been demonstrated in many studies [6–8]. How-
ever, the antimicrobial agents could disrupt the natural 
microbial ecology of the mouth, which might result in 
overgrowth of opportunistic or resistant pathogens [2]. 
Ideally, an antimicrobial agent should not induce drug-
resistance or disrupt the oral microbial ecology.
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Some of the natural products, particularly antimicrobial 
peptides, have received increased attention as promising 
antimicrobial agents [9]. CL(14-25), a dodecapeptide, 
that is a partial region near N-terminus of cyanate lyase 
(CL, EC 4.3.99.1, GenBank ID: Os10g0471300) from 
rice (Oryza sativa L. spp. japonica), is a novel cationic 
α helical antimicrobial peptide with three arginine and 
two lysine residues [10]. CL(14-25) has been shown to 
inhibit the growth and activity of a prominent periodon-
tal pathogen, Porphyromonas gingivalis [11, 12]. In our 
recent in vitro experiments, the CL(14-25) demonstrated 
neutralizing activity against endotoxin of Aggregatibac-
ter actinomycetemcomitans [13] and reduced the biofilm 
formation by P. gingivalis in a dose-dependent man-
ner (unpublished observation). We also found that co-
incubation of CL(14-25) (0.07–0.35 mM) for 4 and 24 h 
induced no significant decrease in the viability of human 
aortic endothelial cells. Following the gavage administra-
tion of 0.2 mg CL(14-25) preparation/mouse to BALB/c 
mice, no significant difference in change in body weight 
was found after 14  days compared to control mice. No 
significant change in behavior or fur coat condition was 
observed (unpublished observation). These findings lead 
us to hypothesize that the CL(14-25) may be useful for 
the control of dental plaque biofilm.
The aim of this pilot study was to evaluate clinically the 
antiplaque effect of CL(14-25) in mouthrinse formula-
tion, using an in  vivo dental plaque regrowth model of 
3-days.
Methods
This study was approved by the ethics committee of 
Tokyo Dental College (No. 386).
Peptides
The amino acid sequences and properties of CL(14-
25) used in this study are summarized in Table  1. The 
sequence of CL(14-25) is identical to that of CH peptide 
reported by Taiyoji et  al. [10]. Chemically synthesized 
CL(14-25) was obtained from Hokkaido System Science 
Co., Ltd. (Sapporo, Japan). Synthetic peptides were puri-
fied to >95  % by reversed-phase high-performance liq-
uid chromatography (RP-HPLC). Molecular weights of 
purified CL peptides were confirmed by matrix-assisted 
laser/desorption ionization–time-of-flight mass spec-
troscopy (MALDI–TOF-MS).
Study population
Participants were recruited from periodontally healthy 
individuals, between November 2013 and December 
2013. Written informed consent was obtained from all 
participants. To qualify, subjects were required to have 
a minimum of 20 natural teeth. Systemic exclusion cri-
teria were the presence of cardiovascular and respira-
tory diseases, systemic inflammatory conditions, such 
as diabetes mellitus, immunodeficiency, and current 
pregnancy or lactation. Current smokers and those with 
history of allergic reactions to rice, several mouthrinse 
components or medications were also excluded. The par-
ticipants received no medication that could affect their 
periodontal conditions, such as antimicrobial agents or 
anti-inflammatory drugs, for at least 3  months prior to 
the microbiological testing.
Mouthrinse formulation and preparation
Two formulations were compared. Test mouthrinse was 
prepared with 0.4  % CL(14-25) and 99.6  % sterilized 
distilled water [CL(14-25) 4.0  mg/ml]. No flavorants or 
preservatives were added. Distilled water was used as 
control (placebo) rinse. Preservation condition of the 
mouthrinse formulations was assessed by a standard 
microbial limit test using spread plate method according 
to the method specified in the Japanese Pharmacopoeia. 
It was found that the mouthrinse formulations can be 
safely stored at both 4 °C and room temperature during 
the study period.
Dental plaque regrowth study
The main outcome variable was plaque score assessed by 
the modified Volpe’s method [14, 15] reported by Suzuki 
et  al. [16]. After disclosing the plaque, a periodontal 
probe was used to measure the height of the plaque accu-
mulation from the gingival margin to the nearest 0.5 mm 
at six sites per Ramfjord index teeth (#16, 21, 24, 36, 41, 
44) [17] considering both buccal and lingual surfaces. 
Clinical examiners were trained in study procedures 
prior to commencement of the study. The plaque score of 
a given tooth was expressed as the absolute value from 
the sum of all six measurements [18].
In Fig. 1, flow diagram of the study is presented. Within 
7 days of the screening examination, eligible participants 
received oral hygiene instructions and professional tooth 
cleaning in order to standardize oral hygiene procedures. 
Through computer-aided randomization, the participants 
were divided in two groups of the same size; Group 1 and 
Group 2. A person not directly involved in the research 
Table 1 The amino acid sequence and properties of CL(14-
25)
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project carried out the allocation of test or control prod-
ucts. A plaque regrowth study design, with a crossover 
design [19, 20], was used. The selected mouthrinse for-
mulation was given to participants in Group 1 and the 
placebo mouthrinse was given to those in Group 2, along 
with the usage instructions. Each participant received 
a bottle containing 125  ml of mouthrinse. They were 
instructed to rinse their mouth with 20  ml of the given 
mouthrinse for 1 min twice a day for 3 days avoiding any 
other oral hygiene manoeuvre. To check for compliance, 
subjects were asked to note the times of day when they 
rinsed.
Fig. 1 Flow diagram illustrating the study design
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Study participants were asked to fill out a questionnaire 
regarding their perception of plaque reduction. Perceived 
plaque reduction was graded on a 5-point rating scale 
with discrete responses, ranging from 0 (insufficient) to 
5 (very sufficient). At the completion of the trial, partici-
pants were asked to choose the mouthrinse formulation 
with which greater plaque reduction was perceived. All 
returned mouthrinse bottles were weighed to calcu-
late the amount of mouth rinse used and to check for 
compliance.
After this period, plaque score was recorded using 
a disclosing solution. A washout period of 7  days sepa-
rated each treatment phase. Then participants resumed 
their normal oral self-care. After this washout period, all 
participants underwent again a session of professional 
tooth cleaning and the protocol continued inverting the 
mouthrinses according to a crossover design and with the 
same timing and mode of use previously described. In 
this way, each subject received both treatments sequen-
tially. Plaque reduction rate was calculated as follows: 
Plaque reduction (%)  =  [(plaque score of the placebo 
rinse) − (plaque score of the test rinse)/(plaque score of 
the placebo rinse)] × 100.
Statistical analysis
The tooth was the unit of analysis. Data were analyzed 
using nonparametric statistics, which are more appro-
priate when the data show a skewed distribution. Thus, 
the Wilcoxon matched-pairs signed-ranks test was used 
to ascertain the differences between the individual rinse 
solutions. Data considering the questionnaire scores 
were also analyzed using the same test. Fisher’s exact test 
was used to compare the association with the two differ-
ent score category between groups.
All data were registered electronically using Microsoft 
Excel, and statistical analyses were carried out using a 
statistical package (InStat 3.10, GraphPad Software, La 




Ten eligible volunteers (all males; age range 26 to 33 years; 
mean age: 28.2) participated in the study. At baseline, 
the mean total plaque score of the examined teeth of the 
participants was 1.18 ±  0.97, as assessed by the scoring 
method by Suzuki et  al. [16]. All participants (N  =  10) 
completed the trial, and there were no missing values.
The amounts of mouthrinses used indicated good 
compliance with the instructions. There were no signifi-
cant adverse events, including mucosal irritation, tooth 
staining and taste alteration in relation to the use of the 
mouthrinse formulations.
Effects on the plaque score
The plaque scores of the teeth examined after the use 
of test or control mouthrinse are shown in Fig. 2. There 
was significant difference in plaque score between the 
CL(14-25) group (2.44 ± 0.74, CI: 1.91–2.96) and the pla-
cebo group (2.65 ± 0.63, CI: 2.20–3.10) (P < 0.05). When 
analyzed according to the types of teeth (Fig.  3), a sig-
nificantly lower mean plaque score was observed in the 
premolars/molars in the CL(14-25) group (2.39  ±  0.68, 
CI: 2.08–2.71) than the placebo group (2.66 ±  0.58, CI: 
2.39–2.93) (P < 0.05) (Fig. 3d).
The mean plaque reduction rate (relative to control 
rinse) of the examined teeth was 8.8 ± 10.4 % (Table 2). 
When analyzed according to tooth surface of the exam-
ined teeth group, the plaque reduction rate was the great-
est (19.7 ± 21.9 %) on the lingual surfaces of molars. In 
contrast, the mean plaque reduction rate was low for 
incisors (4.2 ± 22.2 %). Especially, in lower incisors and 
on lingual surface of incisors, there was no improvement 
in values.
Participants’ perception of plaque reduction
With regard to the perception of plaque reduction, 
no significant difference in score was observed (mean 
scores: 2.4 for the test rinse and 2.3 for the control). The 
number of participants who gave scores higher or equal 
to 3 was 5 in the test group whereas that in the control 
group was 3 (no significant difference, P = 0.650, Fisher’s 
exact test). As for the overall perception of plaque reduc-
tion comparing two different formulations at the com-
pletion of the trial, three participants rated the test rinse 
better than the control rinse and seven rated them as the 
same.
Fig. 2 Plaque scores of the teeth following the use of control 
(placebo) or test mouthrinse: all teeth examined. The line represents 
mean value. (*P < 0.05, Wilcoxon matched-pairs signed-ranks test)
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Discussion
In order to overcome the problems associated with the 
use of conventional antimicrobial agents in oral rinse 
formulations, novel natural antimicrobial ingredients 
have been studied [21–24]. However, evidence provid-
ing the effectiveness of natural compounds containing 
mouthrinse as an adjunct to unsupervised oral hygiene 
for the control of dental plaque is still insufficient [25]. 
In previous studies from our research group, we have 
shown in vitro the various antimicrobial properties of the 
CL(14-25), a deodecapeptide derived from rice [10–13]. 
Based on these findings, we evaluated the antiplaque 
effect of the CL(14-25) in mouthrinse formulation in this 
study. The data demonstrated that rinsing with a 0.4  % 
CL(14-25) solution resulted in a significant decrease in 
the plaque score of the teeth examined. This finding may 
be particularly pertinent in view of the growing interest 
in the use of natural ingredients in healthcare products.
We used a non-brushing model that allowed for dental 
plaque accumulation that has been widely used to evalu-
ate the effects of various mouthrinses [19–22, 26–28]. 
Conducted in the absence of mechanical oral hygiene, 
the method provides direct evidence of the chemical 
action of formulations against plaque growth [29]. Using 
this study design, we have shown that the mean plaque 
reduction rate of the examined teeth was 8.8  %. This 
Fig. 3 Plaque scores of the teeth following the use of control or test mouthrinse: analysis by the tooth type. a incisors, b premolars, c molars, d 
premolars/molars. The line represents mean value. (*P < 0.05, Wilcoxon matched-pairs signed-ranks test)
Table 2 Plaque reduction (%)
Plaque reduction (%) = [(plaque score of the placebo rinse) − (plaque score of the test rinse)/(plaque score of the placebo rinse)] × 100. Data shown as 
means ± standard deviations (lower 95 % confidence interval − upper 95 % confidence interval)
Total Upper Lower Buccal Lingual
Incisor 4.2 ± 22.2 (−11.7 to 20.1) 11.0 ± 32.7 (−12.4 to 34.4) −4.4 ± 26.0 (−23.1 to 14.2) 3.5 ± 36.4 (−22.5 to 29.6) −1.4 ± 36.6 (−27.5 to 24.8)
Molar 12.5 ± 17.4 (0.1 to 30.0) 13.8 ± 17.1 (1.6 to 26.1) 9.3 ± 26.0 (−9.3 to 27.9) 7.0 ± 19.5 (−7.0 to 20.9) 19.7 ± 21.9 (4.0 to 35.4)
Premolar 7.0 ± 15.2 (−3.9 to 17.9) 6.4 ± 18.7 (−7.0 to 19.8) 8.8 ± 20.5 (−5.8 to 23.5) 3.2 ± 15.9 (−8.2 to 14.5) 8.9 ± 29.5 (−12.2 to 30.0)
Molar and premolar 9.8 ± 16.2 (2.2 to 17.3) 10.1 ± 17.9 (1.7 to 18.5) 9.1 ± 22.8 (−1.6 to 19.7) 5.1 ± 17.4 (−3.1 to 13.2) 14.9 ± 25.9 (−2.2 to 26.4)
All teeth examined 8.8 ± 10.4 (1.3 to 16.2) 11.6 ± 12.8 (2.5 to 20.8) 5.7 ± 17.6 (−6.9 to 18.3) 6.7 ± 17.8 (−1.6 to 15.0) 9.2 ± 23.5 (−1.8 to 20.2)
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value is greater than that (~1.9 %) reported with 0.03 % 
sanguinaria extract [29] but is lower than those reported 
with mouthrinses containing essential oil or chlorhex-
idine (reduction rates; 17–38 %) [26–30]. It is difficult to 
directly compare these results, as the evaluation methods 
of plaque accumulation are different. Also, the potential 
difference in the ability to form plaque biofilm between 
participants of different studies may have influenced the 
outcome. Given that no other ingredients were added to 
the CL(14-25) mouthrinse formulations, the data sug-
gest its clinical efficacy in reducing the regrowth of den-
tal plaque. The mechanisms for the reduction in plaque 
regrowth are thought to involve the antimicrobial prop-
erties of the CL(14-25) [11–13], including those against 
periodontal pathogens. We speculate the reduced via-
bility of the biofilm organisms following the use of the 
CL(14-25) mouthrinse.
In this study, we used the plaque scoring method by 
Suzuki et  al. [16], which evaluates the extent of dental 
plaque formation on tooth surface. This scoring method 
has been used in various clinical trials [18, 31–33]. Keep-
ing the difference of scoring methods in mind, the find-
ing that relatively high plaque reduction rate (19.7 %) was 
noted for the lingual surface of molars is similar to that 
by Ramberg et al. [34]. Although the exact reasons for the 
seemingly superior reduction score for the lingual sur-
faces of molars are unclear, this finding may be clinically 
relevant since such region is generally more difficult to 
obtain satisfactory results by mechanical plaque control. 
In contrast, the plaque reduction was minimal for inci-
sors, especially lower incisor and lingual surface. Simi-
lar finding was reported by Pizzo et  al. [35, 36]. It may 
be argued that the lingual surfaces of lower incisors may 
not be adequate in evaluating the plaque reduction by the 
use of mouthrinse, since they are in close contact with 
the tip of tongue, which may influence the early plaque 
regrowth.
No significant difference in participants’ perception of 
plaque reduction was found between groups. It should 
be noted that three individuals rated the CL(14-25) rinse 
better than the placebo rinse in perceived plaque reduc-
tion, although the remaining seven participants rated 
both rinses as the same. We need to further investigate 
the subjective measure of the effect of the CL(14-25) 
mouthrinse, after adding other ingredients necessary for 
the commercial formulation.
It has been reported that the essential oil-containing 
mouthrinse, when used in conjunction with a fluoride 
dentifrice and usual oral hygiene, provided a greater ben-
efit in reducing plaque [37]. This may hold true for the 
present CL(14-25) mouthrinse. This needs to be verified 
with studies incorporating mechanical plaque control 
measures. It is necessary for the antimicrobial agents not 
to disrupt the natural microbial ecology of the mouth, 
which might result in overgrowth of opportunistic or 
resistant pathogens. The long-term effects on the micro-
bial ecology and on the periodontal tissues need to be 
investigated.
There are several limitations to our study. The sam-
ple size was very small and only male participants were 
included. The use of only the index teeth for assess-
ment is another limitation. The choice of plaque scor-
ing method made it difficult to compare the results with 
those reported in the previous reports outside Japan. 
This study is a pilot in nature and provides a framework 
upon which future studies can be based. Further studies 
employing larger sample sizes are necessary to fully eluci-
date the clinical effect(s) of the CL(14-25) on the control 
of dental plaque. Also, it is necessary to test the CL(14-
25) in relation to other ingredients that can be formu-
lated into mouthrinse.
Rice is the staple food in Japan and many other coun-
tries, and people’s general perceptions of this food are 
very favorable. It is relatively affordable, which is impor-
tant in considering the ingredient for mouthrinse formu-
lations. Our findings open up new possibilities for rice, 
in addition to its established role as an excellent dietary 
energy source.
Conclusions
Our data indicate that the CL(14-25) has potential as an 
anti-plaque therapeutic product for oral use and war-
rants further clinical evaluation. The peptide and the for-
mulation appear safe and well-tolerated by experimental 
participants.
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